MEI Pharma Stock Forward View
| MEIPDelisted Stock | USD 3.07 0.18 6.23% |
MEI Stock outlook is based on your current time horizon.
As of today, the value of RSI of MEI Pharma's share price is approaching 43. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling MEI Pharma, making its price go up or down. Momentum 43
Sell Extended
Oversold | Overbought |
Using MEI Pharma hype-based prediction, you can estimate the value of MEI Pharma from the perspective of MEI Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of MEI Pharma on the next trading day is expected to be 2.14 with a mean absolute deviation of 0.50 and the sum of the absolute errors of 30.76. MEI Pharma after-hype prediction price | USD 3.07 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
MEI |
MEI Pharma Additional Predictive Modules
Most predictive techniques to examine MEI price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for MEI using various technical indicators. When you analyze MEI charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
MEI Pharma Naive Prediction Price Forecast For the 21st of February
Given 90 days horizon, the Naive Prediction forecasted value of MEI Pharma on the next trading day is expected to be 2.14 with a mean absolute deviation of 0.50, mean absolute percentage error of 0.43, and the sum of the absolute errors of 30.76.Please note that although there have been many attempts to predict MEI Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that MEI Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
MEI Pharma Stock Forecast Pattern
| Backtest MEI Pharma | MEI Pharma Price Prediction | Research Analysis |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of MEI Pharma stock data series using in forecasting. Note that when a statistical model is used to represent MEI Pharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.2576 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.5042 |
| MAPE | Mean absolute percentage error | 0.1344 |
| SAE | Sum of the absolute errors | 30.7568 |
Predictive Modules for MEI Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MEI Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.MEI Pharma After-Hype Price Density Analysis
As far as predicting the price of MEI Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in MEI Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of MEI Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
MEI Pharma Estimiated After-Hype Price Volatility
In the context of predicting MEI Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on MEI Pharma's historical news coverage. MEI Pharma's after-hype downside and upside margins for the prediction period are 3.07 and 3.07, respectively. We have considered MEI Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
MEI Pharma is very steady at this time. Analysis and calculation of next after-hype price of MEI Pharma is based on 3 months time horizon.
MEI Pharma Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as MEI Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MEI Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with MEI Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 8 Events / Month | 2 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
3.07 | 3.07 | 0.00 |
|
MEI Pharma Hype Timeline
MEI Pharma is now traded for 3.07. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. MEI is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on MEI Pharma is about 0.0%, with the expected price after the next announcement by competition of 3.07. The company recorded a loss per share of 4.75. MEI Pharma last dividend was issued on the 16th of November 2023. The entity had 1:20 split on the 17th of April 2023. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.MEI Pharma Related Hype Analysis
Having access to credible news sources related to MEI Pharma's direct competition is more important than ever and may enhance your ability to predict MEI Pharma's future price movements. Getting to know how MEI Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how MEI Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MTVA | MetaVia | (0.29) | 8 per month | 0.00 | (0.17) | 11.60 | (20.10) | 79.95 | |
| TRAW | Traws Pharma | 0.05 | 9 per month | 9.36 | (0) | 17.44 | (12.90) | 48.86 | |
| ELEV | Elevation Oncology | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PHXM | PHAXIAM Therapeutics SA | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PIRS | Pieris Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DOMH | Dominari Holdings | (0.16) | 11 per month | 0.00 | (0.06) | 5.56 | (7.07) | 24.97 | |
| KA | Kineta Inc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NYMXF | Nymox Pharmaceutical | 0.00 | 0 per month | 0.00 | (0.02) | 36.54 | (23.15) | 82.03 | |
| CSCI | COSCIENS Biopharma | 0.00 | 0 per month | 9.47 | 0.09 | 33.98 | (26.22) | 94.83 | |
| LSB | LakeShore Biopharma Co | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MEI Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MEI Pharma stock to make a market-neutral strategy. Peer analysis of MEI Pharma could also be used in its relative valuation, which is a method of valuing MEI Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
MEI Pharma Market Strength Events
Market strength indicators help investors to evaluate how MEI Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MEI Pharma shares will generate the highest return on investment. By undertsting and applying MEI Pharma stock market strength indicators, traders can identify MEI Pharma entry and exit signals to maximize returns.
MEI Pharma Risk Indicators
The analysis of MEI Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in MEI Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting mei stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.5 | |||
| Semi Deviation | 7.01 | |||
| Standard Deviation | 8.45 | |||
| Variance | 71.4 | |||
| Downside Variance | 64.21 | |||
| Semi Variance | 49.08 | |||
| Expected Short fall | (6.53) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for MEI Pharma
The number of cover stories for MEI Pharma depends on current market conditions and MEI Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that MEI Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about MEI Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
MEI Pharma Short Properties
MEI Pharma's future price predictability will typically decrease when MEI Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of MEI Pharma often depends not only on the future outlook of the potential MEI Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MEI Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6.7 M | |
| Dividends Paid | -11.7 M | |
| Cash And Short Term Investments | 38.3 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in MEI Stock
If you are still planning to invest in MEI Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MEI Pharma's history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |